Cite
HARVARD Citation
Jung, D. et al. (n.d.). 404Switching from Posaconazole (POSA) Suspension to Tablets in Patients with Hematologic Malignancy Results in Increased Serum Levels but no Hepatotoxicity. Open forum infectious diseases. p. S156. [Online].